XA
Longevity Health Holdings Inc.
XAGE · OTC
$0.17 +0.00% (+$0.00)
1M -31.61%
Market Cap $243.0K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.14x
EV/EBITDA N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 404.84%
Op. margin 357.55%
FCF margin 146.06%
Quality
79 /100
Excellent ROA 647.05%
Asset turnover 1.60x
ROIC 72.37%
Debt
0 /100
High Int. coverage -353.83x
Current ratio 0.07x
Net debt/EBITDA N/A
Stability
19 /100
Unstable EPS volatility 402.82%
Profitable years 0
Beta 0.40x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o XAGE
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Janakiram Ajjarapu
Employees
10
Headquarters
Pittsburgh